Stanford Neuroscientist, Robert Malenka, M.D., Ph.D., To Advise Cerevance Post author:Sam Post published:October 4, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Valeant Sells Sprout Pharma to a New Company 'Associated' With Sprout Founders November 5, 2017 Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 Moderna's Vaccines Boss Leaves Company March 6, 2018
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017